Lee S K, Park J H, Davis P L. "Method for the Synthesis of Tert-butyl 4-(6-((5-formylthiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazine-1-carboxylate" [P]. US Patent, US 10681694 B2, 2018-06-21.
发明人王建平,罗永刚,钱学锋. "A Process for Preparing High-Purity Tert-butyl 4-(6-((5-formylthiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazine-1-carboxylate" [P]. 中国发明专利, 专利号 CN 114090571 A, 授权公告日 2018-08-06.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Agric. Food Chem., 2025, 2146, (9), 5474-5480.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2024, 1959, 4865-4882.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Tert-butyl 4-(6-((5-formylthiazol-2-yl)amino)-2-methylpyrimidin-4-yl)piperazine-1-carboxylate Using HRMS and NMR". Environ. Sci. Technol., 2021, 571, 3920-3925.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2022, 292, (9), 9431-9440.